Levosimendan for patients with heart failure undergoing major oncological surgery: A randomised blinded pilot study

BACKGROUND AND AIMS: Cardiovascular diseases and cancer are among the leading causes of mortality worldwide. The aim of this study is to evaluate the efficacy and safety of preoperative administration of levosimendan in patients with chronic heart failure (CHF) scheduled for major abdominal oncologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaker, Ehab H, Hussein, Khaled, Reyad, Ehab M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921323/
https://www.ncbi.nlm.nih.gov/pubmed/31879424
http://dx.doi.org/10.4103/ija.IJA_548_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921323/
https://www.ncbi.nlm.nih.gov/pubmed/31879424
http://dx.doi.org/10.4103/ija.IJA_548_18

Ejemplares similares